X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pulmonary fibrosis (26) 26
fibrosi pulmonar (25) 25
humans (17) 17
index medicus (14) 14
respiratory system (9) 9
male (8) 8
extracellular matrix (7) 7
female (7) 7
fibroblasts (7) 7
research article (7) 7
respiratory tract diseases (7) 7
epithelial cells (6) 6
fibrosis (6) 6
research (6) 6
transforming growth factor beta1 - pharmacology (6) 6
aged (5) 5
cells, cultured (5) 5
expression (5) 5
idiopathic pulmonary fibrosis (5) 5
idiopathic pulmonary fibrosis - metabolism (5) 5
matriu extracel·lular (5) 5
middle aged (5) 5
animals (4) 4
biology (4) 4
collagen (4) 4
fibroblasts - metabolism (4) 4
genetic aspects (4) 4
idiopathic pulmonary fibrosis - pathology (4) 4
signal transduction (4) 4
activation (3) 3
adult (3) 3
autoimmune diseases (3) 3
cancer (3) 3
col·lagen (3) 3
cèl·lules epitelials (3) 3
diseases of the respiratory system (3) 3
esclerodèrmia (3) 3
fibroblasts - drug effects (3) 3
gene expression (3) 3
idiopathic pulmonary-fibrosis (3) 3
immunohistochemistry (3) 3
inhibition (3) 3
lung - metabolism (3) 3
lung diseases (3) 3
malalties autoimmunitàries (3) 3
pathogenesis (3) 3
patients (3) 3
proteins (3) 3
pulmonary and respiratory medicine (3) 3
rats (3) 3
rodents (3) 3
scleroderma (3) 3
616.2 - patologia de l'aparell respiratori (2) 2
a549 cells (2) 2
actins - genetics (2) 2
actins - metabolism (2) 2
aging (2) 2
akt protein (2) 2
analysis (2) 2
apoptosis (2) 2
arteritis (2) 2
article (2) 2
autoantibodies (2) 2
b cells (2) 2
biochemistry (2) 2
biomarkers - metabolism (2) 2
care and treatment (2) 2
case studies (2) 2
case-control studies (2) 2
cell biology (2) 2
cell line (2) 2
cell line, tumor (2) 2
ciències de la salut (2) 2
development and progression (2) 2
diabetes-mellitus (2) 2
diagnosis (2) 2
differentiation (2) 2
envelliment (2) 2
epithelial cells - metabolism (2) 2
epithelial-mesenchymal transition (2) 2
estudi de casos (2) 2
focal adhesion kinase (2) 2
gels (2) 2
genoma humà (2) 2
genotype (2) 2
glicoproteïnes (2) 2
glycoproteins (2) 2
growth (2) 2
growth-factor (2) 2
hemodynamics (2) 2
hepatology (2) 2
human genome (2) 2
human lung fibroblasts (2) 2
hypertension (2) 2
idiopathic pulmonary fibrosis - genetics (2) 2
immunohistoquímica (2) 2
immunology (2) 2
laboratory animals (2) 2
lung fibrosis (2) 2
lungs (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ISSN 1059-1524, 12/2017
The contribution of epithelial-to-mesenchymal transition (EMT) to the profibrotic stiff microenvironment and myofibroblast accumulation in pulmonary fibrosis... 
Cèl·lules epitelials | Pulmonary fibrosis | Epithelial cells | Fibrosi pulmonar
Journal Article
RESPIRATORY RESEARCH, ISSN 1465-993X, 11/2015, Volume 16
Background: There is growing interest in the development of cell culture assays that enable the rigidity of the extracellular matrix to be increased. A... 
RESPIRATORY SYSTEM | Fibroblasts | Fibrosi pulmonar | Pulmonary fibrosis | Col·lagen | Collagen
Journal Article
ISSN 1465-993X, 11/2016
Background: the abnormal epithelial-mesenchymal restorative capacity in idiopathic pulmonary fibrosis (IPF) has been recently associated with an accelerated... 
Immunohistochemistry | Pulmonary fibrosis | Envelliment | Aging | Fibrosi pulmonar | Extracellular matrix | Matriu extracel·lular | Immunohistoquímica
Journal Article
ISSN 1471-2466, 07/2014
Background Idiopathic pulmonary fibrosis (IPF) is a progressive parenchymal lung disease of unknown aetiology and poor prognosis, characterized by altered... 
Glicoproteïnes | Pulmonary fibrosis | Fibrosi pulmonar | Extracellular matrix | Glycoproteins | Matriu extracel·lular
Journal Article
CHRONIC RESPIRATORY DISEASE, ISSN 1479-9723, 08/2019, Volume 16, p. 1479973119869334
Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is defined as a sudden acceleration of the disease with the appearance of pulmonary infiltrates... 
usual interstitial pneumonia | corticosteroid therapy | RESPIRATORY SYSTEM | Idiopathic pulmonary fibrosis | acute exacerbation | RISK | ACETYLCYSTEINE | Fibrosi pulmonar | Corticosteroides | Pulmonary fibrosis | Adrenocortical hormones
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e32785
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is... 
DIABETES-MELLITUS | METABOLIC SYNDROME | CCL4 CIRRHOTIC RATS | FATTY LIVER-DISEASE | INSULIN-RESISTANCE | IN-VIVO | BIOLOGY | NITRIC-OXIDE | NONALCOHOLIC STEATOHEPATITIS | STELLATE CELL ACTIVATION | PORTAL-HYPERTENSION | Metabolic Syndrome - etiology | Liver - pathology | Rats, Wistar | Diet - adverse effects | Fatty Liver - pathology | Fatty Liver - complications | Male | Liver - physiopathology | Inflammation - complications | Microcirculation | Metabolic Syndrome - physiopathology | Non-alcoholic Fatty Liver Disease | Obesity - etiology | Liver Cirrhosis - complications | Fatty Liver - physiopathology | Liver - metabolism | Rats | Obesity - physiopathology | Obesity - pathology | Liver - blood supply | Animals | Endothelium, Vascular - pathology | Splanchnic Circulation | Hemodynamics | Metabolic Syndrome - pathology | Fatty Liver - etiology | Obesity | Liver diseases | Dilatation | Fibrosis | Blood vessels | Insulin resistance | Models | Inflammation | Endothelium | Phosphorylation | Liver | Body weight | Clinical trials | AKT protein | Glucose | Metabolic syndrome | Vasodilation | Fatty liver | Rodents | Hepatology | Atherosclerosis | Hypertension | Complications | Metabolic diseases | Triglycerides | Insulin | Nitric-oxide synthase | Morbidity | Steatosis | Hospitals | Diet | Perfusion | Nitric oxide | Laboratory animals | Metabolic disorders | Fibrosi pulmonar | Malalties del fetge | Pulmonary fibrosis | Endoteli
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2017, Volume 117, Issue 8, pp. 1128 - 1138
Background: Nintedanib is a clinically approved multikinase receptor inhibitor to treat non-small cell lung cancer with adenocarcinoma (ADC) histology in... 
PLACEBO | stroma | CANCER | lung cancer | CARCINOMA-ASSOCIATED-FIBROBLASTS | fibroblasts | TGF-beta | MICROENVIRONMENT | MODELS | ONCOLOGY | BLOCKS | TRIPLE ANGIOKINASE INHIBITOR | GROWTH | DOUBLE-BLIND | nintedanib | fibrosis | PROGRESSION | Cell Line | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Neoplasm Invasiveness | Carcinoma, Squamous Cell - pathology | Humans | Docetaxel | Lung Neoplasms - pathology | Reverse Transcriptase Polymerase Chain Reaction | Adenocarcinoma - drug therapy | Blotting, Western | Indoles - administration & dosage | Taxoids - administration & dosage | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fibroblasts - drug effects | Cell Line, Tumor | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Fibrosis - pathology | Transforming Growth Factor beta1 - pharmacology | Adenocarcinoma | Squamous cell carcinoma | Lung cancer | Parenchyma | Non-small cell lung carcinoma | Activation | Histology | Tumor cell lines | Signaling | Inhibitors | Fibrosis | Fibroblasts | Inhibition | Aberration | Tumors | Cancer | Reacció en cadena de la polimerasa | Polymerase chain reaction | Pulmonary fibrosis | Farmacologia | Fibrosi pulmonar | Pharmacology | Càncer de pulmó | Translational Therapeutics | TGF-β
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 10/2013, Volume 58, Issue 4, pp. 1424 - 1435
Journal Article